Kura Oncology KURA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$73.33M+9.5% | -$81M-9.3% | -$74.12M-12.1% | -$66.12M-15.1% | -$57.43M-199% | ||
| $355K-11.9% | $403K+146% | $164K-26.8% | $224K-7.1% | $241K+18.1% | ||
| $8.42M-25.9% | $11.35M+3.5% | $10.97M+57.8% | $6.95M-11.4% | $7.84M-9.1% | ||
| -$85.85M— | —— | -$80.63M-180% | -$28.78M+60.0% | -$71.93M-127% | ||
| $128K-94.5% | $2.32M-9.6% | $2.57M+76.1% | $1.46M+399% | $292K-21.5% | ||
| -$24.23M+62.5% | -$64.6M-169% | $93.97M— | —— | -$101.41M-6.8% | ||
| $69K-93.9% | $1.14M— | $0-100% | $515K+260% | $143K-82.3% | ||
| -$110.02M— | —— | —— | —— | -$173.19M-199% | ||
| -$85.98M— | —— | -$83.19M-175% | -$30.24M+58.1% | -$72.22M-127% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Kura Oncology generate?
- Kura Oncology (KURA) generated -$267.2M in operating cash flow over the trailing twelve months.
- What is Kura Oncology's free cash flow?
- After $6.5M of capital expenditures, Kura Oncology's free cash flow was -$271.6M over the trailing twelve months, down 302.9% year over year.
- Where does Kura Oncology's cash flow data come from?
- Every line is extracted from Kura Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
